PLIANT THERAPEUTICS INC's ticker is PLRX and the CUSIP is 729139105. A total of 139 filers reported holding PLIANT THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 0.37 and the average weighting 1.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $71,805,004 | -6.6% | 4,141,004 | -2.4% | 0.01% | 0.0% |
| Q2 2023 | $76,865,451 | -68.1% | 4,242,023 | -53.2% | 0.01% | -45.5% |
| Q1 2023 | $241,076,576 | +183.9% | 9,063,030 | +106.3% | 0.01% | +37.5% |
| Q4 2022 | $84,921,160 | -33.2% | 4,393,231 | -27.8% | 0.01% | -38.5% |
| Q3 2022 | $127,147,000 | +374.9% | 6,086,493 | +82.1% | 0.01% | +333.3% |
| Q2 2022 | $26,772,000 | -24.8% | 3,342,271 | -34.1% | 0.00% | 0.0% |
| Q1 2022 | $35,578,000 | -51.2% | 5,075,325 | -6.1% | 0.00% | -40.0% |
| Q4 2021 | $72,979,000 | -19.8% | 5,405,849 | +0.3% | 0.01% | -28.6% |
| Q3 2021 | $90,995,000 | -42.0% | 5,390,690 | +0.1% | 0.01% | -41.7% |
| Q2 2021 | $156,787,000 | -25.6% | 5,384,168 | +0.4% | 0.01% | -33.3% |
| Q1 2021 | $210,837,000 | +74.4% | 5,360,728 | +0.7% | 0.02% | +63.6% |
| Q4 2020 | $120,919,000 | +0.4% | 5,322,156 | +0.1% | 0.01% | -8.3% |
| Q3 2020 | $120,420,000 | -30.4% | 5,316,516 | -0.3% | 0.01% | -36.8% |
| Q2 2020 | $173,100,000 | – | 5,332,701 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TRV GP III, LLC | 1,839,160 | $35,550,963 | 27.86% |
| TRV GP IV, LLC | 2,132,867 | $41,228,319 | 17.53% |
| CHI Advisors LLC | 3,169,892 | $61,274,012 | 16.32% |
| GREAT POINT PARTNERS LLC | 1,322,870 | $25,571,077 | 5.01% |
| VR Adviser, LLC | 1,080,000 | $20,876,400 | 3.52% |
| Redmile Group, LLC | 3,878,599 | $74,973,319 | 3.07% |
| Casdin Capital, LLC | 1,675,000 | $32,377,750 | 2.51% |
| Fernwood Investment Management, LLC | 304,573 | $5,887,396 | 2.44% |
| Cheyne Capital Management (UK) LLP | 66,144 | $1,278,564 | 2.23% |
| First Light Asset Management, LLC | 1,057,881 | $20,448,840 | 1.90% |